Peptide-Based CoVac-1 Vaccine Shows Promise Against COVID-19 in Patients with Cancer.
- Published in:
- Value-Based Cancer Care, 2022, v. 13, n. 3, p. 6
- By:
- Publication type:
- Article
Works matching IS 21534888 AND DT 2022 AND VI 13 AND IP 3
Results: 16
1
2
Kymriah Receives Accelerated FDA Approval for Relapsed or Refractory Follicular Lymphoma.
- Published in:
- Value-Based Cancer Care, 2022, v. 13, n. 3, p. 6
- Publication type:
- Article
3
Nivolumab plus Ipilimumab Shows Promising Activity in the Neoadjuvant Setting for Patients with MSI/dMMR Oeso-Gastric Adenocarcinoma.
- Published in:
- Value-Based Cancer Care, 2022, v. 13, n. 3, p. 14
- By:
- Publication type:
- Article
4
Updated Results from KEYNOTE-564 Trial Confirm Benefit of Adjuvant Pembrolizumab in Patients with Renal-Cell Carcinoma at High Risk for Recurrence.
- Published in:
- Value-Based Cancer Care, 2022, v. 13, n. 3, p. 13
- By:
- Publication type:
- Article
5
The Role of Telehealth in the Delivery of Cancer Care: Exploring Ongoing Opportunities and Challenges.
- Published in:
- Value-Based Cancer Care, 2022, v. 13, n. 3, p. 12
- By:
- Publication type:
- Article
6
Yescarta First CAR T-Cell Therapy FDA Approved for Patients with Large B-Cell Lymphoma.
- Published in:
- Value-Based Cancer Care, 2022, v. 13, n. 3, p. 11
- Publication type:
- Article
7
Updates to Screening and Surveillance Recommendations for Colorectal Cancer.
- Published in:
- Value-Based Cancer Care, 2022, v. 13, n. 3, p. 1
- By:
- Publication type:
- Article
8
Family History of Primary Liver Cancer Associated with Increased Risk for Extrahepatic CCA.
- Published in:
- Value-Based Cancer Care, 2022, v. 13, n. 3, p. 9
- Publication type:
- Article
9
FDA Grants Enhertu Regular Approval for Patients with Unresectable or Metastatic Breast Cancer.
- Published in:
- Value-Based Cancer Care, 2022, v. 13, n. 3, p. 8
- Publication type:
- Article
10
Vidaza Now Approved for Patients with Newly Diagnosed Juvenile Myelomonocytic Leukemia.
- Published in:
- Value-Based Cancer Care, 2022, v. 13, n. 3, p. 8
- Publication type:
- Article
11
Genetic Score Makes PSA Screening More Accurate.
- Published in:
- Value-Based Cancer Care, 2022, v. 13, n. 3, p. 8
- By:
- Publication type:
- Article
12
Tibsovo Receives a New Indication, in Combination with Onureg, for Newly Diagnosed Patients with AML and IDH1 Mutation.
- Published in:
- Value-Based Cancer Care, 2022, v. 13, n. 3, p. 6
- Publication type:
- Article
13
Strategies to Lower Drug Costs Top the Public’s Health Priorities for Congress.
- Published in:
- Value-Based Cancer Care, 2022, v. 13, n. 3, p. 1
- Publication type:
- Article
14
Darolutamide plus ADT and Docetaxel Improves Survival in Men with Metastatic Hormone- Sensitive Prostate Cancer.
- Published in:
- Value-Based Cancer Care, 2022, v. 13, n. 3, p. 1
- By:
- Publication type:
- Article
15
TOPAZ-1: Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer.
- Published in:
- Value-Based Cancer Care, 2022, v. 13, n. 3, p. 1
- Publication type:
- Article
16
Neoadjuvant Chemoimmunotherapy May Be New Standard of Care for Patients with Resectable NSCLC.
- Published in:
- Value-Based Cancer Care, 2022, v. 13, n. 3, p. 1
- By:
- Publication type:
- Article